ALIVUS LIFE SCIENCES
|
ALIVUS LIFE SCIENCES Last 5 Year Balance Sheet History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr |
| Equity - Authorised | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr |
| Equity - Issued | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr |
| Equity Paid Up | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
| Share Warrants & Outstandings | ₹7.25 Cr | ₹9.97 Cr | ₹11 Cr | ₹6.68 Cr | ₹3.50 Cr |
| Total Reserves | ₹3,300 Cr | ₹2,783 Cr | ₹2,297 Cr | ₹2,107 Cr | ₹2,026 Cr |
| Securities Premium | ₹1,019 Cr | ₹1,006 Cr | ₹1,005 Cr | ₹1,005 Cr | ₹1,005 Cr |
| Capital Reserves | - | - | - | - | - |
| Profit & Loss Account Balance | ₹2,282 Cr | ₹1,777 Cr | ₹1,292 Cr | ₹1,102 Cr | ₹1,021 Cr |
| General Reserves | - | - | - | - | - |
| Other Reserves | - | - | - | - | - |
| Reserve excluding Revaluation Reserve | ₹3,300 Cr | ₹2,783 Cr | ₹2,297 Cr | ₹2,107 Cr | ₹2,026 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹3,332 Cr | ₹2,817 Cr | ₹2,332 Cr | ₹2,138 Cr | ₹2,054 Cr |
| Minority Interest | - | - | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | - | - | - | - | - |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | - | - | - | - | - |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | - | - | - | - |
| Unsecured Loans | - | - | - | - | - |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹58 Cr | ₹54 Cr | ₹49 Cr | ₹42 Cr | ₹31 Cr |
| Deferred Tax Assets | ₹12 Cr | ₹7.32 Cr | ₹4.55 Cr | ₹1.81 Cr | ₹1.07 Cr |
| Deferred Tax Liability | ₹70 Cr | ₹62 Cr | ₹53 Cr | ₹44 Cr | ₹33 Cr |
| Other Long Term Liabilities | ₹49 Cr | ₹51 Cr | ₹15 Cr | ₹17 Cr | ₹1.20 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹36 Cr | ₹361 Cr | ₹693 Cr | ₹7.87 Cr | - |
| Total Non-Current Liabilities | ₹143 Cr | ₹466 Cr | ₹757 Cr | ₹67 Cr | ₹33 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹372 Cr | ₹390 Cr | ₹369 Cr | ₹427 Cr | ₹308 Cr |
| Sundry Creditors | ₹372 Cr | ₹390 Cr | ₹369 Cr | ₹427 Cr | ₹308 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹99 Cr | ₹63 Cr | ₹58 Cr | ₹55 Cr | ₹50 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹4.87 Cr | ₹2.97 Cr | ₹5.26 Cr | ₹1.94 Cr | ₹1.13 Cr |
| Interest Accrued But Not Due | - | - | - | - | - |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹94 Cr | ₹60 Cr | ₹53 Cr | ₹53 Cr | ₹49 Cr |
| Short Term Borrowings | - | - | - | - | - |
| Secured ST Loans repayable on Demands | - | - | - | - | - |
| Working Capital Loans- Sec | - | - | - | - | - |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | - | - | - | - | - |
| Short Term Provisions | ₹211 Cr | ₹17 Cr | ₹12 Cr | ₹533 Cr | ₹389 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹181 Cr | - | - | ₹525 Cr | ₹375 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹30 Cr | ₹17 Cr | ₹12 Cr | ₹7.67 Cr | ₹14 Cr |
| Total Current Liabilities | ₹682 Cr | ₹470 Cr | ₹439 Cr | ₹1,015 Cr | ₹747 Cr |
| Total Liabilities | ₹4,157 Cr | ₹3,754 Cr | ₹3,528 Cr | ₹3,220 Cr | ₹2,834 Cr |
| ASSETS | |||||
| Gross Block | ₹1,367 Cr | ₹1,219 Cr | ₹1,012 Cr | ₹936 Cr | ₹706 Cr |
| Less: Accumulated Depreciation | ₹329 Cr | ₹264 Cr | ₹207 Cr | ₹156 Cr | ₹116 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹1,038 Cr | ₹955 Cr | ₹805 Cr | ₹781 Cr | ₹590 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹273 Cr | ₹94 Cr | ₹101 Cr | ₹49 Cr | ₹92 Cr |
| Non Current Investments | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr |
| Long Term Investment | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr |
| Quoted | - | - | - | - | - |
| Unquoted | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr |
| Long Term Loans & Advances | ₹12 Cr | ₹361 Cr | ₹701 Cr | ₹9.49 Cr | ₹20 Cr |
| Other Non Current Assets | - | - | - | - | - |
| Total Non-Current Assets | ₹1,334 Cr | ₹1,418 Cr | ₹1,612 Cr | ₹852 Cr | ₹706 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹780 Cr | ₹478 Cr | - | - | - |
| Quoted | - | - | - | - | - |
| Unquoted | ₹780 Cr | ₹478 Cr | - | - | - |
| Inventories | ₹692 Cr | ₹674 Cr | ₹667 Cr | ₹604 Cr | ₹516 Cr |
| Raw Materials | ₹227 Cr | ₹206 Cr | ₹174 Cr | ₹168 Cr | ₹165 Cr |
| Work-in Progress | ₹409 Cr | ₹421 Cr | ₹408 Cr | ₹371 Cr | ₹310 Cr |
| Finished Goods | ₹37 Cr | ₹29 Cr | ₹68 Cr | ₹49 Cr | ₹25 Cr |
| Packing Materials | ₹1.75 Cr | ₹1.74 Cr | ₹1.29 Cr | ₹1.21 Cr | ₹1.25 Cr |
| Stores  and Spare | ₹17 Cr | ₹17 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr |
| Other Inventory | - | - | - | - | - |
| Sundry Debtors | ₹1,073 Cr | ₹970 Cr | ₹765 Cr | ₹807 Cr | ₹673 Cr |
| Debtors more than Six months | ₹21 Cr | ₹21 Cr | ₹25 Cr | ₹4.16 Cr | ₹0.59 Cr |
| Debtors Others | ₹1,053 Cr | ₹950 Cr | ₹741 Cr | ₹803 Cr | ₹673 Cr |
| Cash and Bank | ₹2.13 Cr | ₹71 Cr | ₹302 Cr | ₹309 Cr | ₹512 Cr |
| Cash in hand | ₹0.04 Cr | ₹0.01 Cr | ₹0.04 Cr | ₹0.09 Cr | ₹0.11 Cr |
| Balances at Bank | ₹2.10 Cr | ₹71 Cr | ₹302 Cr | ₹309 Cr | ₹512 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹39 Cr | ₹42 Cr | ₹92 Cr | ₹72 Cr | ₹5.96 Cr |
| Interest accrued on Investments | - | - | - | - | - |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹6.31 Cr | ₹2.26 Cr | ₹0.81 Cr | ₹0.14 Cr | ₹0.16 Cr |
| Other current_assets | ₹32 Cr | ₹40 Cr | ₹91 Cr | ₹72 Cr | ₹5.79 Cr |
| Short Term Loans and Advances | ₹237 Cr | ₹100 Cr | ₹91 Cr | ₹577 Cr | ₹420 Cr |
| Advances recoverable in cash or in kind | ₹14 Cr | ₹8.26 Cr | ₹15 Cr | ₹18 Cr | ₹37 Cr |
| Advance income tax and TDS | ₹174 Cr | - | - | ₹518 Cr | ₹363 Cr |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹50 Cr | ₹92 Cr | ₹76 Cr | ₹41 Cr | ₹19 Cr |
| Total Current Assets | ₹2,824 Cr | ₹2,335 Cr | ₹1,916 Cr | ₹2,369 Cr | ₹2,127 Cr |
| Net Current Assets (Including Current Investments) | ₹2,141 Cr | ₹1,865 Cr | ₹1,477 Cr | ₹1,354 Cr | ₹1,381 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹4,157 Cr | ₹3,754 Cr | ₹3,528 Cr | ₹3,220 Cr | ₹2,834 Cr |
| Contingent Liabilities | ₹4.82 Cr | ₹4.82 Cr | ₹4.82 Cr | ₹2.22 Cr | ₹2.22 Cr |
| Total Debt | - | - | - | - | - |
| Book Value | 270.90 | 229.11 | 189.45 | 173.97 | 167.38 |
| Adjusted Book Value | 270.90 | 229.11 | 189.45 | 173.97 | 167.38 |
Compare Balance Sheet of peers of ALIVUS LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALIVUS LIFE SCIENCES | ₹16,726.6 Cr | -0.6% | 23.3% | 39.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
ALIVUS LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALIVUS LIFE SCIENCES | -0.6% |
23.3% |
39.2% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses